Heska Corp
HSKA.O- Latest Trade
- trading lower119.88USD
- -0.02
- 0.01%
- As of Jun 6 2023. Values delayed up to 15 minutes
- Today's Range
- 119.83 - 119.88
- 52 Week Range
- 57.83 - 119.90
- Previous Close
- 119.89
- Open
- 119.87
- Volume
- 26,209.00
- 3 Month Average Trading Volume
- 6.37
- Shares Out (Mil)
- 10.91
- Market Cap
- 1,308.45
- Forward P/E
- -141.88
- Dividend Yield
- 0.00
Key Statistics
2.50 mean rating - 4 analysts
- P/E Excl. Extra Items (TTM)
- 0.00
- Price To Sales (TTM)
- 5.13
- Price To Book (Quarterly)
- 3.13
- Price To Cash Flow (Per Share TTM)
- 0.00
- Total Debt/Total Equity (Quarterly)
- 23.03
- Long Term Debt/Equity (Quarterly)
- 22.99
- Return On Investment (TTM)
- -3.35
- Return On Equity (TTM)
- -3.11
2021 (millions USD)
About Heska Corp (HSKA.O)
Company Information
Heska Corporation sells, manufactures, markets and supports diagnostic and specialty products and solutions for veterinary practitioners. The Company’s portfolio includes point-of-care (POC) diagnostic laboratory instruments and consumables, POC digital imaging diagnostic products, local and cloud-based data services, practice information management software (PIMS) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products, and vaccines. The Company has two segments. The North America segment consists of the United States, Canada and Mexico. The segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory. The International segment consists of geographies outside of North America, primarily its operations in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The segment includes its PIMS business and veterinary laboratories.
Address
3760 Rocky Mountain AveLOVELAND, CO
80538-7084
United States
Industry
Medical Equipment & Supplies
Executive Leadership
- Scott W. Humphrey
- Independent Chairman of the Board
- Kevin S. Wilson
- President, Chief Executive Officer, Director
- Catherine I. Grassman
- Chief Financial Officer, Executive Vice President
- Christopher D. Sveen
- Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary, Heska and President, Diamond Animal Health
- Eleanor F. Baker
- Executive Vice President, Managing Director and Chief Operating Officer scil animal care company
- Steven M. Eyl
- Executive Vice President, Chief Commercial Officer, and President, scil animal care company
- Anthony Providenti
- Executive Vice President - Corporate Development
- Robert L. Antin
- Independent Director
- Stephen L. Davis
- Independent Director
- Mark F. Furlong
- Independent Director
- Joachim A. Hasenmaier
- Independent Director
- Sharon J. Maples
- Independent Director
- David E. Sveen
- Independent Director
Latest News
- MarketsU.S. RESEARCH ROUNDUP Akamai Technologies, Gitlab, RPM International
Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Akamai Technologies, Gitlab and RPM International, on Thursday.
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,961.30 | 0.17% |
| Copper | 722.65 | 0.21% |
| Brent Crude Oil | 76.23 | 0.63% |
| CBOT Soybeans | 1,349.25 | 0.06% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,283.80 | 0.23% |
| Euro STOXX 50 | 4,295.22 | 0.05% |
| FTSE 100 | 7,628.10 | 0.37% |
| Nikkei 225 | 32,506.78 | 0.90% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes